Novo Nordisk (NVO) said Friday it will replace Chief Executive Lars Fruergaard Jorgensen, citing a sharp tumble for Novo shares amid growing competition for its popular diabetes and obesity drugs Oze… [+5972 chars]Read More
Novo Nordisk Sheds 3 After Ousting CEO As Eli Lilly Rivalry Slams Stock Price Investors Business Daily
